American Journal of Cardiology
Volume 96, Issue 6 , Pages 806-809 , 15 September 2005

Impact of Beta-Blocker Therapy at Discharge on Long-Term Mortality After Primary Angioplasty for ST-Segment Elevation Myocardial Infarction

Received 28 December 2004 ,Revised 4 May 2005 ,Accepted 4 May 2005.

References 

  1. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, et al  1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practise Guidelines (Committee on Management of Acute Myocardial infarction) . Circulation . 1999;100:1016–1030
  2. Hjalmarson A, Herlitz J, Holmberg S, Ryden L, Swedberg K, Vedin A, et al  The Goteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction . Circulation . 1983;67:I26–I32
  3. Chadda K , Goldstein S , Byington R , Curb JD . Effect of propranolol after acute myocardial infarction in patients with congestive heart failure . Circulation . 1986;73:503–510
  4. Gottlieb SS , McCarter RJ , Vogel RA . Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction . N Engl J Med . 1998;339:489–497
  5. Stenestrand U , Wallentin L  Swedish Register of Cardiac Intensive Care (RIKS-HIA) . Early statin treatment following acute myocardial infarction and 1-year survival . JAMA . 2001;285:430–436
  6. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O’Keefe J, et al  A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group . N Engl J Med . 1993;328:673–679
  7. Zijlstra F, Hoorntje JC, de Boer MJ, Reiffers S, Miedema K, Ottervanger JP, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction . N Engl J Med . 1999;341:1413–1419
  8. Keeley EC , Boura JA , Grines CL . Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction (a quantitative review of 23 randomised trials) . Lancet . 2003;361:13–20
  9. Suryapranata H , van ‘t Hof A , Hoorntje JCA , de Boer MJ , Zijlstra F . Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction . Circulation . 1998;97:2502–2505
  10. Antoniucci D, Migliorini A, Parodi G, Valenti R, Rodriguez A, Hempel A, et al. Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival (a prospective, multicenter, randomized trial comparing infarct artery stenting plus abciximab with stenting alone) . Circulation . 2004;109:1704–1706
  11. De Luca G, van’t Hof AW, de Boer MJ, Hoorntje JC, Gosselink AT, Dambrink JH, et al. Impaired myocardial perfusion is a major explanation of the poor outcome observed in patients undergoing primary angioplasty for ST-segment-elevation myocardial infarction and signs of heart failure . Circulation . 2004;109:958–961
  12. van’t Hof AW , Liem A , Suryapranata H , Hoorntje JC , de Boer MJ , Zijlstra F . Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction. Myocardial blush grade . Circulation . 1998;97:2302–2306
  13. Kernis SJ, Harjai KJ, Stone GW, Grines LL, Boura JA, O’Neill WW, et al. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty? . J Am Coll Cardiol . 2004;43:1773–1779

PII: S0002-9149(05)01026-X

doi: 10.1016/j.amjcard.2005.05.025

American Journal of Cardiology
Volume 96, Issue 6 , Pages 806-809 , 15 September 2005

Article Tools

* Image Usage & Resolution